comparemela.com

Latest Breaking News On - Gni group ltd stock exchange - Page 1 : comparemela.com

GNI : summary Q&A from Q1 2023 financial results analyst call and other recent inquiries

This presentation contains statements concerning the current plans, expectations, and strategies of GNI. | May 23, 2023

United statesContinent pharmaceuticals co ltdBerkeley advanced biomaterialsCatalyst biosciences incGroup ltdProtein degradationGni group ltd stock exchangePress releaseF 2160 jp3386370005

GNI : FY2023Q1 Earnings Call Transcript

This presentation contains statements concerning the current plans, expectations, and strategies of GNI. | May 22, 2023

United statesBerkeley advanced biomaterialsContinent pharmaceuticals co ltdCatalyst biosciences incGroup ltdProtein degradationMedical deviceGni group ltd stock exchangePress releaseF 2160 jp3386370005

GNI : Amendment of Q1 FY2023 Financial Results Corporate Presentation document

May 18, 2023 Company Name: . | May 18, 2023

United statesGroup ltdGrowth board of the tokyo stock exchangeGroup incGrowth boardTokyo stock exchangeGni group ltd stock exchangePress releaseOmpany 2160 jp3386370005

GNI : Q1 FY2023 Financial Results Corporate Presentation

GNI Group Ltd. FY2023 Q1 Financial Results Corporate Presentation . | May 17, 2023

Group ltdBring new hopeGni group ltd stock exchangePress releaseOrporate 2160 jp3386370005

GNI : CBIO submits Form 8-K regarding its Nasdaq listing status

Please be advised that Catalyst Biosciences, Inc. , one of our affiliates, filed 8-K to SEC today regarding its listing status at Nasdaq. For more details, please. | May 6, 2023

Catalyst biosciences incCatalyst biosciencesGni group ltd stock exchangePress releaseOre 2160 jp3386370005

vimarsana © 2020. All Rights Reserved.